NEWS: 公告在东京证券交易所JASDAQ标准市场新上市



US Retina Quarterly Update

出版商 Market Scope, LLC 商品编码 960919
出版日期 年间契约型资讯服务 内容资讯 英文
美国的视网膜市场:季报 US Retina Quarterly Update
出版日期: 年间契约型资讯服务内容资讯: 英文




  • 各疾病及各产品的玻璃体内 (IVT) 注射
  • Eylea, Lucentis, Avastin, Macugen, Visudyne PDT的使用
  • 糖尿病黄斑部水肿 (DME) 治疗
  • 皮质类固醇的使用
  • 光凝固数量和光凝固剂的使用
  • 玻璃体切除的数量与位置
  • 玻璃体切除机的使用与市场占有率
  • 可重复使用、抛弃式的器具
  • 视觉化剂

更新资讯中,包含过去数年收集资讯的比较为基础的趋势分析。还有包含美国的视网膜手术 (IVT注射)的全年预测,及与前一年的比较。


Our coverage of the US retina market includes a quarterly surveying process that targets and collects data from retina specialists. The resulting data are analyzed and presented in our US Retina Surgery Quarterly Updates. These updates are designed to improve your decision-making process with an assessment of current market conditions and the identification of significant market trends -- including retinal patient care, product use and market share, product adoption plans, and doctors' evaluations of pharmaceuticals and surgical equipment.

Each update includes full-year forecasts, comparisons with prior years, and trend analysis.

We measure and analyze key metrics of the US retinal market four times per year, including:

  • IVT injections by disease and product;
  • Use of Eylea, Lucentis, Avastin, Macugen, and Visudyne PDT;
  • DME treatments;
  • Corticosteroid use;
  • Photocoagulation volume and photocoagulators used;
  • Vitrectomy volume and location;
  • Vitrectomy machine use and market share;
  • Reusable and disposable instruments.
  • Visualization agents

Our updates include trend analysis based on comparisons with information gathered in previous years. We also provide a full-year forecast for US retinal procedures (including IVT injections) and a comparison with volumes during the prior year.